1. Homepagina
  2. Aandelen
  3. België
  4. Euronext Bruxelles
  5. Mithra Pharmaceuticals S.A.
  6. Nieuws
  7. Persberichten
    MITRA   BE0974283153

MITHRA PHARMACEUTICALS S.A.

(MITRA)
  Rapport
Real Time Euronext Bruxelles  -  26/05 17:35:03 CEST
7.060 EUR   -1.67%
16/05Degroof Petercam verlaagt koersdoel Mithra
AM
13/05Mithra haalt geld op bij LDA Capital
AM
12/05Mithra presenteert studieresultaten met Donesta
AM
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciënConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAndere talenPersberichtenOfficiële publicatiesSectornieuwsAnalyse MarketScreener
Communiqués de presse de la société MITHRA PHARMACEUTICALS S.A.
16/05Mithra Issues a Put Option Notice Under Capital Agreement with LDA Capital
AQ
09/05Mithra - Publication of a Transparency Notification Received from Glenernie Capital
AQ
02/05Mithra - Publication of Transparency Notifications Received from Goldman Sachs
AQ
26/04MITHRA PHARMACEUTICALS S A : CDMO Announces Collaboration with MedinCell for the Developme..
PU
20/04Mithra Releases Invitation to its General Ordinary and Extraordinary Securities holders..
AQ
19/04MITHRA PHARMACEUTICALS S A : Releases Invitation to its General Ordinary and Extraordinary..
PU
18/04Mithra Releases 2021 Annual Report
AQ
18/04MITHRA PHARMACEUTICALS S A : Announces the Extension of the Capital Commitment Agreement w..
PU
15/04MITHRA PHARMACEUTICALS : Releases 2021 Annual Report
PU
14/04Mithra Announces Improved Consolidated Topline Results from Donesta Phase 3 Studies and..
AQ
14/04MITHRA PHARMACEUTICALS S A : Announces Improved Consolidated Topline Results from Donesta®..
PU
08/04MITHRA PHARMACEUTICALS S A : Publication of a Transparency Notification Received from Gold..
PU
29/03MITHRA PHARMACEUTICALS S A : Publication of a Transparency Notification Received from Fran..
PU
29/03MITHRA PHARMACEUTICALS S A : Publication of a Transparency Notification Received from Gold..
PU
24/03Mithra - Publication of a Transparency Notification Received from Goldman Sachs
AQ
23/03MITHRA PHARMACEUTICALS S A : Publication of a Transparency Notification Received from Gold..
PU
21/03MITHRA PHARMACEUTICALS S A : Exercise of a Second Drawing Request under Equity Funding Agr..
PU
08/03MITHRA PHARMACEUTICALS S A : Reports Full Year 2021 Financial Results
PU
01/03Mithra - Publication of a Transparency Notification Received from Francois Fornieri
AQ
28/02Mithra - Publication of a Transparency Notification Received from Alychlo
AQ
28/02Mithra - Publication of a Transparency Notification Received from Goldman Sachs
AQ
25/02MITHRA PHARMACEUTICALS S A : Publication of a Transparency Notification Received from Gold..
PU
17/02Mithra and Searchlight Pharma Announce Launch of Haloette in Canada
AQ
17/02Mithra - Publication of a Transparency Notification Received from Francois Fornieri
AQ
07/02MITHRA PHARMACEUTICALS S A : Obtains Equity Funding for up to EUR 100 Million
PU
17/01Mithra Announces Positive Top-Line Results
AQ
14/01MITHRA PHARMACEUTICALS S A : Announces Positive Top-Line Results from Donesta® Phase 3 Stu..
PU
11/01Publication of a Transparency Notification Received from Francois Fornieri
AQ
10/01MITHRA PHARMACEUTICALS S A : Publication of a Transparency Notification Received from Fran..
PU
2021MITHRA PHARMACEUTICALS S A : Issues a Put Option Notice Under Capital Agreement with LDA C..
PU
2021Mayne pharma and mithra announce tga approval of nextstellis oral contraceptive
AQ
2021MITHRA PHARMACEUTICALS S A : Mayne Pharma and Mithra Announce TGA Approval of Nextstellis®..
PU
2021MITHRA PHARMACEUTICALS S A : holds today its Investor Day at CDMO
PU
2021Mithra organizes its Investor Day on November 29, 2021
PU
2021MITHRA PHARMACEUTICALS S A : Announces Estelle Launch in Belgium
AQ
2021MITHRA PHARMACEUTICALS S A : Announces Estelle® Launch in Belgium
PU
2021MITHRA PHARMACEUTICALS S A : The Board of Directors confirms Leon Van Rompay as Mithra's C..
PU
2021MITHRA PHARMACEUTICALS S A : Provides FDA Update on Myring
AQ
2021MAYNE PHARMA : Provides fda update on generic nuvaringo
AQ
2021MITHRA PHARMACEUTICALS S A : Provides FDA Update on Myring®
PU
2021MITHRA PHARMACEUTICALS S A : Announces the Appointment of its Representative to Mayne Phar..
AQ
2021MITHRA PHARMACEUTICALS S A : Announces the Appointment of its Representative to Mayne Phar..
PU
2021MITHRA PHARMACEUTICALS S A : Announces Topline Results for COVID-19 Phase II Study
AQ
2021MITHRA PHARMACEUTICALS S A : Announces Topline Results for COVID-19 Phase II Study
PU
2021MITHRA PHARMACEUTICALS S A : Interim Financial Report as at 30 June 2021
PU
2021MITHRA PHARMACEUTICALS S A : Announces 2021 Half Year Results
PU
2021MITHRA PHARMACEUTICALS S A : Half Year 2021 Results
PU
2021MITHRA PHARMACEUTICALS S A : Announces an Update on PeriNesta
AQ
2021MITHRA PHARMACEUTICALS S A : Announces an Update on PeriNesta®
PU
2021DONESTA® PHASE III : Recruitment Completion of American Study and Additional Recruitment i..
PU
2021MITHRA PHARMACEUTICALS S A : to Host Webcast for Half Year Financial Results on 24 Septemb..
PU
2021MITHRA PHARMACEUTICALS S A : Announces Estelle® Approval in Russia
PU
2021MITHRA PHARMACEUTICALS S A : and Searchlight Pharma Announce Availability of Nextstellis® ..
PU
2021MITHRA PHARMACEUTICALS S A : extends the pricing period for the put option announced on Ju..
PU
2021MITHRA PHARMACEUTICALS S A : ExeVir and Mithra announce manufacturing collaboration for in..
PU
2021MITHRA PHARMACEUTICALS S A : Issues a Put Option Notice Under Capital Agreement with LDA C..
AQ
2021MITHRA PHARMACEUTICALS S A : Issues a Put Option Notice Under Capital Agreement with LDA C..
PU
2021MITHRA PHARMACEUTICALS S A : successfully renegotiates the earnouts relating to its Comple..
AQ
2021MITHRA PHARMACEUTICALS S A : successfully renegotiates the earnouts relating to its Comple..
PU
2021Estelle Oral Contraceptive Now Available In the United States
AQ
2021MITHRA PHARMACEUTICALS : Estelle® Oral Contraceptive Now Available In The United States
PU
2021Mayne - Nextstellis Receives FDA Marketing Exclusivity And Phase III Data Published
AQ
2021MAYNE PHARMA : Nextstellis receives fda marketing exclusivity and phase iii data published
AQ
2021MITHRA PHARMACEUTICALS S A : Nextstellis® Receives FDA Marketing Exclusivity and Phase III..
PU
2021MITHRA PHARMACEUTICALS S A : Announces European Approval of Estelle
AQ
2021MITHRA PHARMACEUTICALS S A : Announces European Approval of Estelle®
PU
2021MITHRA PHARMACEUTICALS S A : takes note of François Fornieri's indictment
PU
2021MITHRA PHARMACEUTICALS S A : Releases 2020 Annual Report and Invitation to its Securities ..
AQ
2021MITHRA PHARMACEUTICALS S A : Releases 2020 Annual Report and Invitation to its Securities ..
PU
2021MITHRA PHARMACEUTICALS S A : Transparency Notification from Alychlo NV
PU
2021MITHRA PHARMACEUTICALS S A : Publication of a Transparency Notification Received from Alyc..
PU
2021MAYNE PHARMA : And mithra announce fda approval of new oral contraceptive nextstellis
AQ
2021Mayne Pharma and Mithra Announce FDA Approval of New Oral Contraceptive Estelle
AQ
2021Richter and Mithra Receive Positive CHMP Opinion for Estelle
AQ
2021MITHRA PHARMACEUTICALS S A : Richter and Mithra Receive Positive CHMP Opinion for Estelle®
PU
1  2  3  4  5Volgende
Volgende evenement op MITHRA PHARMACEUTICALS S.A.